A defensible comparison of pulmonary function testing equipment begins by fixing the test protocol and reporting obligation before listing instruments. A NIOSH-affiliated occupational screening clinic and a hospital-based laboratory may both perform spirometry, but the first must reconstruct raw forced expiratory maneuvers for external quality review, while the second may prioritize diffusing capacity and linked spirometry across multiple devices. Identifying that operational difference narrows the field to equipment that can meet a specific evidentiary requirement, rather than equipment that merely carries a general ATS/ERS compliance claim. The comparison then proceeds through four decision points: required electronic output, stated performance accuracy, what manufacturers assert versus what independent variability testing demonstrates, and the calibration or quality-control burden a facility can sustain. Each step depends on primary documents rather than accumulated marketing materials, and several material facts remain unknowable from public sources alone.

Start from the Required Data Output, Especially the Raw Waveform

NIOSH's Coal Workers' Health Surveillance Program states that approved facilities must use spirometers meeting federal regulations and that electronic spirometry data files must include raw flow data points sampled at 100 Hz or greater for each forced expiratory maneuver [1]. The agency explains that this sampling rate allows NIOSH to reconstruct individual maneuver spirometry curves for miner testing quality review [1]. A purchasing decision shaped only by the presence of real-time volume-time and flow-volume displays could therefore miss the disqualifying limitation that stored output falls below the sampling rate required for this specific federal program.

The 2019 ATS/ERS technical statement takes a broader device specification approach, covering equipment specifications, display requirements, BTPS adjustment, and data reporting [2]. The update states that manufacturers must ensure all spirometers meet the current ISO 26782 standard, identified in the source as ISO 26782:2009, and that it is not permissible to recalibrate a spirometer between the individual test profiles of Annex C [7]. A comparison request should therefore ask a vendor to state which ISO 26782 edition a model meets and whether it was tested against the standard's full profiles, because that single line item determines whether the instrument belongs on a shortlist for clinical or research use under the 2019 update.

The distinction matters most when equipment will support multiple programs. One system may meet NIOSH export rules for a mining respiratory surveillance contract but still require a separate review for an employer-sponsored respirator clearance program. Public sources do not provide a single crosswalk showing which models satisfy every federal or accreditation requirement simultaneously, so procurement staff must treat each data transfer standard as an independent acceptance criterion and request written confirmation from the manufacturer for each intended use.

Translate Accuracy Claims into a Testable, Documented Specification

Manufacturer accuracy language is only comparable when reduced to the same measurement metric. MGC Diagnostics' CPFS/D USB promotional sheet states a flow range of ±18 L/s, resolution of 8.65 mL/s, accuracy of ±2% or 50 mL, whichever is greater, and resistance below 1.5 cm H2O/L/s at 14 L/s, which the vendor says exceeds ATS/ERS specifications [5]. The same document claims the preVent flow sensor was independently validated and shown to meet ATS recommendations for accuracy against the 24 standard waveforms of Hankinson and Graner for FVC, FEV1, and FEF 25-75% [5]. These are vendor-asserted figures and validation references, not an endorsement by a public health agency.

A separate benchmark comes from the College of Physicians & Surgeons of Alberta's 2026 best practice guideline, which expects equipment to meet ISO 26782:2009 and describes a maximum permissible error of not more than ±2.5% when tested with a 3-L calibration syringe using the test profiles of ISO 26782, Section 7 [8]. That tolerance is narrower than the general ±3.0% accuracy, linearity, and repeatability language the same guideline cites from the standard [8]. When a manufacturer sheet does not express accuracy in identical terms, the evaluation can still record the stated conditions—flow range, resolution, syringe volume, and waveform set—and flag whether the vendor has supplied the underlying test report rather than a summary line.

OSHA's occupational spirometry guidance frames accuracy as freedom from error and precision as repeatability, illustrating the point with a 3-L input that should repeatedly record as 3 L [4]. The guidance does not name a preferred manufacturer model, and its cover and figure captions explicitly state that product images do not represent an official OSHA endorsement [4]. That disclaimer is a useful reminder that regulatory citations do not convert a brochure specification into agency validation.

A Suggested Three-Column Comparison Worksheet

A procurement committee could create three columns for each shortlisted instrument: required evidence, vendor-stated specification, and verification method. For a NIOSH-affiliated screening site, row one would record raw flow data at 100 Hz or greater with CSV or XML transfer, entering the manufacturer's written confirmation and sampling rate [1]. Row two would record ISO 26782:2009 compliance and whether the vendor states testing against the standard's full profiles [7].

Row three would request performance against ATS waveform validation, such as the 24 Hankinson and Graner waveforms cited in the MGC Diagnostics sheet, with the underlying report rather than the summary line [5]. Row four would record daily calibration verification against the Alberta low-medium-high flow protocol, along with whether the same in-line filter is used during calibration and testing [8]. A separate interference-logic row would note that no retrieved document supports an across-vendor numerical accuracy ranking, so any such figure in a vendor presentation should be treated as unsupported until the full test protocol and denominator are supplied.

Compare Like-for-Like Devices Using Variability Data, Not Shared Branding

A realistic comparison of two same-brand instruments appears in a 2025 abstract examining the VitaloLAB laboratory system and VitaloROV+ portable system [6]. Eight healthy volunteers were recruited, and the source reports that DLco readings were collected using two different VitaloLAB devices and two different VitaloROV+ devices with daily calibration, biological QC, and mechanical QC [6]. Complete data were available for five subjects, yielding 80 individual DLco data points, and the abstract states that the majority of coefficient of variation values were at or below the 3.1% target, with remaining values exceeding that target by 0.11 to 2.17% [6].

The authors concluded that the two systems provided consistent and comparable results over successive maneuvers and recommended that manufacturers perform inter- and intra-device testing to give users confidence in results [6]. This finding applies to a specific instrument pair in a small healthy-volunteer sample and does not establish how either device performs in patient populations with obstructive or restrictive disease. Procurement teams can use the abstract as an example of the kind of evidence to request from any vendor—measured inter-session and intra-session variability, device count, operator count, and sample denominator—rather than as a reason to prefer one platform.

The missing comparison for most procurement decisions is direct head-to-head variability between different manufacturers' systems in the intended setting. Public sources here describe one vendor's internal product line comparison and a separate manufacturer's individually stated specifications. No retrieved document provides a third-party matrix showing CPFS/D against VitaloLAB against EasyOne Air or the NIOSH-listed Benson and Depisteo models under identical testing conditions, so a comparative numerical ranking would exceed the evidence.

Weight the Calibration, Verification, and Reprocessing Workflow

The Alberta guideline specifies daily calibration verification at low, medium, and high flow using a 3.0 L syringe cycled at least three times to give flows between 0.5 and 12.0 L/s, with measured volume at each flow within ±3% for both inspiration and expiration, or expiration only for volume-based spirometers [8]. It also requires that an in-line filter used during testing be used in-line during calibration and calls for a calibration syringe accuracy of at least 0.5% of full scale, or ±0.015 L for a 3.0 L syringe [8]. These steps convert a one-time purchase into a daily staffing and consumables obligation that differs from the vendor claim on the CPFS/D sheet that its preVent flow sensor needs no recalibration or warm-up between patients [5].

The two statements are not necessarily contradictory: the CPFS/D language concerns between-patient warm-up and recalibration within a session, while the Alberta requirement concerns daily verification against a syringe. The evaluation should record both and ask whether the manufacturer's no-recalibration claim eliminates the daily low-medium-high verification sequence or only removes a sub-step. Infection control adds another reprocessing variable, since the Alberta guideline states that portions of an inspired pathway exposed to expired air should be sterilized between patients and that a non-sterilizable machine requires another strategy [8]. A unit with a disposable sensor may shift cost from labor-intensive disinfection to consumable purchasing, but the sources do not supply per-test consumable pricing for any model.